This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.
Latest papers
Perspectives of Adolescents and Young Adults With Inflammatory Bowel Disease on a Biopsychosocial Transition Intervention: Qualitative Interview Study.
JMIR pediatrics and parenting · 2025
Reflections on youth partnership in a randomized controlled trial of an intervention to optimize transition from pediatric to adult care in inflammatory bowel disease.
Health care transitions · 2025
Mental Health Experiences of Adolescents and Young Adults with Inflammatory Bowel Disease During Transition to Adult Care: A Qualitative Descriptive Study.
The Journal of pediatrics · 2024
Latest funding
- $10,000
Consensus Statements for the Use of Routinely Collected Health Data in Inflammatory Bowel Disease Research
CIHR · 2022 · Co-investigator
- $2,399,999
Training Researchers In the Next generation in Gastroenterology and Liver (TRIANGLE)
CIHR · 2021 · Principal investigator
36 publications.
Perspectives of Adolescents and Young Adults With Inflammatory Bowel Disease on a Biopsychosocial Transition Intervention: Qualitative Interview Study.
Allemang B, Miatello A, Browne M, Barwick M, Maini P, Eszczuk J, Pandit C, Sadhra T, Forhan L, Bollegala N, Fu N, Lee K, Dekker E, Nistor I, Ahola Kohut S, Keefer L, Griffiths AM, Walters TD, Micsinszki S, Mack DR, Lawrence S, Kroeker KI, de Guzman J, Tausif A, Tersigni C, Anthony SJ, Benchimol EI
Reflections on youth partnership in a randomized controlled trial of an intervention to optimize transition from pediatric to adult care in inflammatory bowel disease.
Allemang B, Miatello A, Maini P, Eszczuk J, Tersigni C, Micsinszki S, Dave S, Bollegala N, Fu N, Lee K, Anthony SJ, Barwick M, Benchimol EI
Mental Health Experiences of Adolescents and Young Adults with Inflammatory Bowel Disease During Transition to Adult Care: A Qualitative Descriptive Study.
Allemang B, Browne M, Barwick M, Bollegala N, Fu N, Lee K, Miatello A, Dekker E, Nistor I, Ahola Kohut S, Keefer L, Micsinszki S, Walters TD, Griffiths AM, Mack DR, Lawrence S, Kroeker KI, de Guzman J, Tausif A, Maini P, Tersigni C, Anthony SJ, Benchimol EI
The 2023 Impact of Inflammatory Bowel Disease in Canada: Indirect (Individual and Societal) and Direct Out-of-Pocket Costs.
Kuenzig ME, Im JHB, Coward S, Windsor JW, Kaplan GG, Murthy SK, Benchimol EI, Bernstein CN, Bitton A, Jones JL, Lee K, Peña-Sánchez JN, Rohatinsky N, Ghandeharian S, Jones May T, Tabatabavakili S, Jogendran R, Weinstein J, Khan R, Hazan E, Browne M, Davis T, Goddard Q, Gorospe J, Latos K, Mason K, Kerr J, Balche N, Sklar A, Targownik LE
The 2023 Impact of Inflammatory Bowel Disease in Canada: Epidemiology of IBD.
Coward S, Benchimol EI, Kuenzig ME, Windsor JW, Bernstein CN, Bitton A, Jones JL, Lee K, Murthy SK, Targownik LE, Peña-Sánchez JN, Rohatinsky N, Ghandeharian S, Im JHB, Davis T, Weinstein J, Goddard Q, Bennett J, Caplan L, Bergevin M, Yang XY, Mason K, Sanderson R, Brass C, Kaplan GG
The 2023 Impact of Inflammatory Bowel Disease in Canada: Direct Health System and Medication Costs.
Kuenzig ME, Coward S, Targownik LE, Murthy SK, Benchimol EI, Windsor JW, Bernstein CN, Bitton A, Jones JL, Lee K, Peña-Sánchez JN, Rohatinsky N, Ghandeharian S, Im JHB, Jogendran R, Meka S, Weinstein J, Jones May T, Jogendran M, Tabatabavakili S, Hazan E, Hu M, Osei JA, Khan R, Wang G, Browne M, Davis T, Goddard Q, Gorospe J, Latos K, Mason K, Kerr J, Balche N, Sklar A, Kaplan GG
The 2023 Impact of Inflammatory Bowel Disease in Canada: COVID-19 and IBD.
Kaplan GG, Kuenzig ME, Windsor JW, Bernstein CN, Bitton A, Coward S, Jones JL, Lee K, Murthy SK, Targownik LE, Peña-Sánchez JN, Ghandeharian S, Rohatinsky N, Weinstein J, Jones May T, Browne M, Jannati N, Tabatabavakili S, Im JHB, Meka S, Vukovic S, Davis T, Goddard Q, Gorospe J, Stocks T, Caplan L, Kanaan N, Stuart D, Ramsay T, Robinson KJ, Charron-Bishop D, Benchimol EI
The 2023 Impact of Inflammatory Bowel Disease in Canada: Executive Summary.
Windsor JW, Kuenzig ME, Murthy SK, Bitton A, Bernstein CN, Jones JL, Lee K, Targownik LE, Peña-Sánchez JN, Rohatinsky N, Ghandeharian S, Im JHB, Davis T, Weinstein J, Goddard Q, Benchimol EI, Kaplan GG
Multi-national observational study to assess quality of life and treatment preferences in patients with Crohn's perianal fistulas.
Karki C, Athavale A, Abilash V, Hantsbarger G, Geransar P, Lee K, Milicevic S, Perovic M, Raven L, Sajak-Szczerba M, Silber A, Yoon A, Tozer P
The 2023 Impact of Inflammatory Bowel Disease in Canada: Special Populations-IBD in Seniors.
Shaffer SR, Kuenzig ME, Windsor JW, Bitton A, Jones JL, Lee K, Murthy SK, Targownik LE, Peña-Sánchez JN, Rohatinsky N, Ghandeharian S, Tandon P, St-Pierre J, Natt N, Davis T, Weinstein J, Im JHB, Benchimol EI, Kaplan GG, Goddard Q, Gorospe J, Bergevin M, Silver K, Bowles D, Stewart M, Pearlstein M, Dawson EH, Bernstein CN
Consensus Statements for the Use of Routinely Collected Health Data in Inflammatory Bowel Disease Research
Principal investigators: Benchimol, Eric I
Keywords: Epidemiology; Health Administrative Data; Health Services Research; Inflammatory Bowel Disease; Pharmacoepidemiology; Research Education; Research Methodology; Routinely Collected Health Data
Training Researchers In the Next generation in Gastroenterology and Liver (TRIANGLE)
Principal investigators: Jones, Nicola L; Bhat, Mamatha; Hirota, Simon A; Kaplan, Gilaad G; Lee, Kate; McKay, Derek M; Otley, Anthony R; Pena-Sanchez, Juan-Nicolas; Perreault, Nathalie; Reynolds, Lisa A; Rose, Christopher; Targownik, Laura E; Vallance, Bruce A; Verdu, Elena F
Keywords: Gastroenterology; Health Research Training Program; Liver
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Pediatrics
- Medicine
- Biology
- Community Health Sciences
- Department of Psychiatry
- Physiology and Pharmacology
- Community Health and Epidemiology
- Other
Co-authors at University of Toronto, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Alain Bitton
Faculty
29 shared papers, latest 2023
Noelle Rohatinsky
Faculty
12 shared papers, latest 2023
Harminder Singh
Biology
6 shared papers, latest 2023
Harminder Singh
Community Health Sciences
6 shared papers, latest 2023
Sharyle Fowler
Community Health and Epidemiology
4 shared papers, latest 2023
Remo Panaccione
Physiology and Pharmacology
4 shared papers, latest 2021
Melanie Barwick
Department of Psychiatry
4 shared papers, latest 2025
Brooke Allemang
Faculty
3 shared papers, latest 2025
Jean-Eric Ghia
Immunology
3 shared papers, latest 2021
John Kenneth Marshall
Medicine
2 shared papers, latest 2021
Reena Khanna
Medicine
2 shared papers, latest 2021
Sara Ahola Kohut
Faculty
2 shared papers, latest 2025
Harminder Singh
Faculty
2 shared papers, latest 2019
Laura Targownik
Pediatrics
1 shared papers, latest 2021
Arif Jetha
Social & Behavioural Health Sciences Division
1 shared papers, latest 2022
Eytan Wine
Pediatrics
1 shared papers, latest 2023
Eric Benchimol
Department of Paediatrics
1 shared papers, latest 2021
Alexander Mcgirr
Psychiatry
1 shared papers, latest 2021
Signe Bray
Radiology
1 shared papers, latest 2021
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.